The collaboration with Microsoft to implement advanced digital technologies, including generative AI and robust data governance, is a progressive move that enhances innovation in drug discovery and patient care. This initiative supports a forward-thinking, anti-fascist approach by empowering scientific research and promoting transparency and efficiency within biopharmaceutical operations.

Almirall and Microsoft announce partnership for digital transformation to enable the development of novel treatments for skin diseases